Monday, May 7, 2018

The American Association of Neuropathologists Awarded R13 Conference Grant by National Institute on Aging

The American Association of Neuropathologists (AANP) today announced that it has been awarded an R13 Support for Conferences and Scientific Meetings grant through the National Institute on Aging of the National Institutes of Health. This grant will support the 94th Annual Meeting of the AANP in Louisville, KY.

Dr. Edward Lee
“We are extremely pleased to be recipients of an R13 grant to support dissemination of the critical work completed by our members and featured by our annual meeting,” said Assistant Secretary Treasurer/Chair of the Education Committee, Edward Lee, MD, PhD. “The National Plan to Address Alzheimer’s Disease calls for the prevention and treatment of Alzheimer’s disease and related dementias (ADRD) by 2025. Critical to this goal is the role of neuropathologists in describing the neuropathology associated with ADRD and aging. To this end, the annual AANP meeting provides the most direct means to disseminate the latest developments in ADRD and aging-related neuropathologies.”

The purpose of the R13 grant through the NIA is to support the ADRD and aging components of conferences and scientific meetings, to better disseminate latest developments related to pathologic heterogeneity in dementia and aging. Specific to the AANP, this grant aims to enhance the education of neuropathology trainees about ADRD and aging to attract the next-generation of ADRD neuropathologists. Notably, this grant markedly expands the support available for trainees to attend the annual meeting such that 30 trainees will receive trainee travel awards this year.

This year’s 94th Annual Meeting will kick-off on Thursday, June 7 with the first half of the Special Course: Neuropathology of Aging featuring the following speakers: Elizabeth Mormino, PhD, Stanford University; John Crary, MD, PhD, Icahn School of Medicine at Mount Sinai; Peter Nelson, MD, PhD, University of Kentucky; and Julie Schneider, MD, MS, Rush University Medical Center. The DeArmond Lecture: Dysregulated Metabolism in the Pathogenesis of Alzheimer’s Disease: Type 3 Diabetes will take place on Friday featuring Suzanne de la Monte, MD, MPH, of the Warren Alpert Medical School of Brown University. In addition, multiple platform sessions throughout the meeting will focus on aging and neurodegenerative diseases including sessions on
Alzheimer’s disease, chronic traumatic encephalopathy, frontotemporal lobar degeneration, Lewy body disease and prion disease. Lastly, this year will also include the first-ever Award for Best Neurodegenerative Disease Case Presented at the 2018 Diagnostic Slide Session.

“We are thrilled to be R13 grant recipients,” said current AANP President Elizabeth Cochran, MD. “Thank you to everyone who dedicated time and focus in developing our proposal, and thank you to the National Institute on Aging for their support.”

No comments:

Dr. Diamandis develops network to help pathologists interface with AI computational scientists

A neuropathology colleague in Toronto (Dr. Phedias Diamandis) is developing some amazing AI-based tools for pathology and academia. He hel...